Evidence map›Paper›PMID 32569301›Full record

ArticlePLoS biology2020

NCX1 represents an ionic Na+ sensing mechanism in macrophages.

Patrick Neubert, Arne Homann, David Wendelborn, Anna-Lorena Bär, Luka Krampert, Maximilian Trum, Agnes Schröder, Stefan Ebner, Andrea Weichselbaum, Valentin Schatz and 16 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. HvNCX, a prime candidate gene for the novel qualitative locus qS7.1 associated with salinity tolerance in barley.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2023
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. High NaFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 4 countries.

Patrick NeubertInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.
Arne HomannInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.
David WendelbornInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.
Anna-Lorena BärInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.
Luka KrampertInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.ORCID 0000-0002-8835-6145
Maximilian TrumDepartment of Internal Medicine II, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.ORCID 0000-0002-8267-2681
Agnes SchröderInstitute of Orthodontics, University Hospital of Regensburg, Regensburg, Germany.ORCID 0000-0001-6010-9831
Stefan EbnerInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.
Andrea WeichselbaumInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.
Valentin SchatzInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.ORCID 0000-0001-7784-8753
Peter LinzInstitute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.ORCID 0000-0002-8232-1443
Roland VeelkenDepartment of Internal Medicine 4, University Hospital Erlangen, Erlangen, Germany.ORCID 0000-0002-4254-6322
Jonas Schulte-SchreppingDepartment for Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.ORCID 0000-0001-7333-8924
Anna C AschenbrennerDepartment for Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.ORCID 0000-0002-9429-5457
Thomas QuastMolecular Immunology and Cell Biology LIMES Institute, University of Bonn, Bonn, Germany.
Christian KurtsInstitute of Experimental Immunology, University of Bonn, Bonn, Germany.
Sabrina GeisbergerExperimental and Clinical Research Center (ECRC), a cooperation of Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.ORCID 0000-0001-6477-1312
Karl KunzelmannInstitute of Physiology, University of Regensburg, Regensburg, Germany.ORCID 0000-0001-6222-4593
Karin HammerDepartment of Internal Medicine II, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.ORCID 0000-0003-2015-0682
Katrina J BingerDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, Australia.ORCID 0000-0003-1139-3308
Jens TitzeCardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore.ORCID 0000-0001-8463-8404
Dominik N MüllerExperimental and Clinical Research Center (ECRC), a cooperation of Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine, Berlin, Germany.
Waldemar KolanusMolecular Immunology and Cell Biology LIMES Institute, University of Bonn, Bonn, Germany.ORCID 0000-0003-1325-9444
Joachim L SchultzeDepartment for Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.ORCID 0000-0003-2812-9853
Stefan WagnerDepartment of Internal Medicine II, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.ORCID 0000-0002-9471-1166
Jonathan JantschInstitute of Clinical Microbiology and Hygiene, University Hospital of Regensburg and University of Regensburg, Regensburg, Germany.ORCID 0000-0001-6944-2913
University Hospital Regensburg · DEUniversity of Bonn · DEMax Delbrück Center · DEDuke-NUS Medical School · SGFriedrich-Alexander-Universität Erlangen-Nürnberg · DELa Trobe University · AUUniversitätsklinikum Erlangen · DEUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation and infection can trigger local tissue Na+ accumulation. This Na+-rich environment boosts proinflammatory activation of monocyte/macrophage-like cells (MΦs) and their antimicrobial activity. Enhanced Na+-driven MΦ function requires the osmoprotective transcription factor nuclear factor of activated T cells 5 (NFAT5), which augments nitric oxide (NO) production and contributes to increased autophagy. However, the mechanism of Na+ sensing in MΦs remained unclear. High extracellular Na+ levels (high salt [HS]) trigger a substantial Na+ influx and Ca2+ loss. Here, we show that the Na+/Ca2+ exchanger 1 (NCX1, also known as solute carrier family 8 member A1 [SLC8A1]) plays a critical role in HS-triggered Na+ influx, concomitant Ca2+ efflux, and subsequent augmented NFAT5 accumulation. Moreover, interfering with NCX1 activity impairs HS-boosted inflammatory signaling, infection-triggered autolysosome formation, and subsequent antibacterial activity. Taken together, this demonstrates that NCX1 is able to sense Na+ and is required for amplifying inflammatory and antimicrobial MΦ responses upon HS exposure. Manipulating NCX1 offers a new strategy to regulate MΦ function.

Indexed as

Alternative SplicingAnimalsCalciumExtracellular SpaceGene SilencingIon Channel GatingIonsLipopolysaccharidesMacrophagesMiceNitric OxideRAW 264.7 CellsSodiumSodium-Calcium ExchangerSodium ChlorideCalciumIonsLipopolysaccharidesNitric OxideSodiumSodium-Calcium Exchangersodium-calcium exchanger 1Sodium Chloride

Identifiers

PMID32569301
PMCPMC7307728
OpenAlexW3036798427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.